Freyssin A, Carles A, Moha B, Rubinstenn G, Maurice T. Long-Term Treatment with Fluoroethylnormemantine (FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice. ACS Pharmacol Transl Sci. 2024 Dec 13;7(12):4069-4082. Epub 2024 Dec 2 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.